CymaBay Therapeutics, Inc.

CITADEL ADVISORS LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

330,234

Value ($000)

7,800

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	7,800	0.0%	330,234	12/31/2023
2023 Q3	11/14/2023	1,689	0.0%	113,307	9/30/2023
2023 Q2	8/14/2023	4,922	0.0%	449,462	6/30/2023
2023 Q1	5/15/2023	2,842	0.0%	325,886	3/31/2023
2022 Q4	2/14/2023	8,532	0.0%	1,360,815	12/31/2022
2022 Q3	11/14/2022	4,731	0.0%	1,351,657	9/30/2022
2022 Q2	8/15/2022	3,864	0.0%	1,309,877	6/30/2022
2022 Q1	5/16/2022	3,007	0.0%	966,877	3/31/2022
2021 Q4	2/14/2022	2,320	0.0%	686,434	12/31/2021
2021 Q3	11/15/2021	404	0.0%	110,629	9/30/2021
2021 Q2	8/16/2021	1,536	0.0%	352,297	6/30/2021
2021 Q1	5/21/2021	7,178	0.0%	1,580,975	3/31/2021
2020 Q4	2/16/2021	14,484	0.0%	2,523,425	12/31/2020
2020 Q3	11/16/2020	16,084	0.0%	2,221,555	9/30/2020
2020 Q2	8/14/2020	9,423	0.0%	2,700,098	6/30/2020
2020 Q1	5/15/2020	3,943	0.0%	2,664,233	3/31/2020
2019 Q4	2/14/2020	5,599	0.0%	2,856,288	12/31/2019